Improve patient care with UpToDate® 

Medical professionals rely on UpToDate for clinical information they can trust.

Subscribe risk-free 

UpToDate is a clinical decision support resource that helps more than 2 million medical professionals provide better patient care. With over 7,300 contributors who are leaders in their medical fields, UpToDate is like having an experienced colleague by your side — a colleague deeply knowledgeable about the latest medical advances across 25 clinical specialties.

UpToDate adapts quickly to the latest global developments in medicine, such as research on treatment and prevention of COVID-19, including the impact of the Delta variant. Content is updated continuously to address the needs of physicians and other medical professionals globally.1

With a personal subscription to UpToDate, you will benefit from:

  • UpToDate® Advanced. Included in newly purchased individual subscriptions, UpToDate Advanced consists of lab monographs and accompanying algorithms to help you quickly interpret abnormal results and choose next steps, and interactive evidence-based pathways that can help you address specific clinical questions.*

  • Hands-free voice search in our mobile app. Say what you’re looking for and our voice-enabled search will find the answers you need fast.

  • A select set of foundational drug information. UpToDate provides access to select medication monographs and interactive tools from our drug reference, Lexicomp®.

Subscribe risk-free

Clinicians who subscribe say2...

  • 98% would recommend UpToDate to a colleague

  • 98% trust UpToDate as an evidence-based clinical information resource

  • 96% say UpToDate improves the care they provide to their patients

  • 96% report that UpToDate adds confidence to their decision making

  • 96% say UpToDate keeps them current

  • 94% state they are able to find answers to most of their clinical questions in UpToDate

 

  • ‹ prev
  • next ›
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
You can manage your SMS communication options by clicking 
here.